Summary
A small clinical trial with the Glenn type 3 poliovirus vaccine has shown that the strain is antigenic and retains its attenuated characters on human passage at least as well as any other reported type 3 strain. The antigenicity and stability of the various type 3 vaccine strains should be compared in a larger clinical trial.
Similar content being viewed by others
References
Barnes, J. M., C. S. Heymann, andA. J. Beale: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases, Stockholm. Published by Masson et Cie, Paris (1963); p. 283.
Benyesh-Melnick, M., andJ. L. Melnick: First International Conference on Live Poliovirus Vaccines. Scientific Publication No. 44; p. 179. Published by Pan American Sanitary Bureau. Regional Office of the W.H.O. Washington (1959).
Clarke, S. K. A., A. P. Goffe, C. H. Stuart Harris, andE. G. Herzog: Brit. med. J.ii, 1188 (1958).
Galbraith, N. S.: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases. Stockholm. Published by Masson et Cie, Paris; (1963); p. 92.
Henderson, D. A., J. J. Witte, L. Morris, andA. D. Langmuir: J. Amer. med. Ass.190, 40 (1964).
Hoskins, J. M.: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases, Stockholm. Published by Masson et Cie, Paris; (1963); p. 290.
Miller, D. L., andN. S. Galbraith: Brit. med. J.ii, 504 (1965).
Plotkin, S. A., T. W. Norton, Barbara J. Cohen, andH. Koprowski: Proc. Soc. exp. Biol. (N.Y.)107, 829 (1961).
Sabin, A. B.: J. Amer. med. Ass.162, 1589 (1956).
Sabin, A. B.: Brit. med. J.i, 663 (1959).
Sabin, A. B.: Second International Conference on Live Poliovirus Vaccines. Scientific Publication 50 p. 101. Published by Pan American Sani tary Bureau. Regional Office of the W.H.O. Washington (1960).
Stones, P.: International Symposium on Neurovirulence, Munich 1965; Symp. Series immunobiol Standard.2, 211 (1966).
Terry, L. L.: A Technical Report. U.S. Dept. Hlth. Educ. Welfare (1962).
Vogt, M., R. Dulbecco, andH. A. Wenner: Virology4, 141 (1957).
W.H.O.: Expert Committee on Poliomyelitis Third Report. Wld Hlth Org. techn. Rep. Ser. No. 203 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnes, J.M., Heymann, C.S., Galbraith, N.S. et al. A clinical trial of Glenn type 3 attenuated poliovirus vaccine. Archiv f Virusforschung 20, 296–304 (1967). https://doi.org/10.1007/BF01241949
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01241949